Publications by authors named "Alexa Green"

Claim this Profile
T
Transforming tropical peatland governance to manage climate risks using the Three Horizons method.
Mark S Reed, Dianna Kopansky, Sam Beechener, Alexa Green, Patrick Scheel

PLoS One· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring policy coherence for land use transformations: The case of Scotland.
Hebe Nicholson, Kirsty Blackstock, Jean Boucher, James Glendinning, Alexa Green

J Environ Manage· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Don't judge lymphocytosis by its flow.
Noémie Lang, Alexa Samantha Green

Blood· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of therapy-induced myelodysplastic syndrome by infusion of autologous CD34-positive hematopoietic progenitor cells without chemotherapy.
Anne-Sophie Alary, Marguerite Vignon, Raphael Carapito, Najeeb Halabi, Lise Willems, Alexa Green

Leuk Lymphoma· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicted Reversal in N-Methylazepine/N-Methyl-7-azanorcaradiene Equilibrium Upon Formation of Their N-Oxides.
René Fournier, Alexa R Green, Arthur Greenberg, Edward Lee-Ruff, Joel F Liebman

Molecules· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational Study of Selected Amine and Lactam N-Oxides Including Comparisons of N-O Bond Dissociation Enthalpies with Those of Pyridine N-Oxides.
Arthur Greenberg, Alexa R Green, Joel F Liebman

Molecules· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1-tube panel strategy for diagnosis and prognosis of patients with MDS.
Sylvain Barreau, Alexa S Green, Charles Dussiau, Anne-Sophie Alary, Anna Raimbault

Cytometry B Clin Cytom· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pernicious mean corpuscular volume.
Alexa S Green, Nicolas Chapuis

Blood· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FLT3 inhibitors: clinical potential in acute myeloid leukemia.
Marie-Anne Hospital, Alexa S Green, Thiago T Maciel, Ivan C Moura, Anskar Y Leung

Onco Targets Ther· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pim kinases modulate resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD acute myeloid leukemia.
Alexa S Green, Thiago T Maciel, Marie-Anne Hospital, Chae Yin, Fetta Mazed

Sci Adv· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia.
Pierre Sujobert, Laury Poulain, Etienne Paubelle, Florence Zylbersztejn, Adrien Grenier, Alexa S Green

Cell Rep· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CHK1 inhibits cell proliferation in FLT3-ITD positive acute myeloid leukemia.
Ling Li Yuan, Alexa Green, Laure David, Christine Dozier, Christian Récher

Leuk Res· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.
Lise Willems, Nathalie Jacque, Arnaud Jacquel, Nathalie Neveux, Thiago Trovati Maciel, Alexa S Green

Blood· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The eukaryotic initiating factor 4E protein is overexpressed, but its level has no prognostic impact in acute myeloid leukaemia.
Alexa S Green, Sophie Grabar, Micheline Tulliez, Sophie Park, Chadi Al-Nawakil

Br J Haematol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cells.
Marie-Anne Hospital, Alexa S Green, Catherine Lacombe, Patrick Mayeux, Didier Bouscary

Blood· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High levels of CD34+CD38low/-CD123+ blasts are predictive of an adverse outcome in acute myeloid leukemia: a Groupe Ouest-Est des Leucemies Aigues et Maladies du Sang (GOELAMS) study.
François Vergez, Alexa S Green, Jerome Tamburini, Jean-Emmanuel Sarry, Baptiste Gaillard

Haematologica· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology.
Alexa S Green, Nicolas Chapuis, Catherine Lacombe, Patrick Mayeux, Didier Bouscary

Cell Cycle· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.
Alexa S Green, Nicolas Chapuis, Thiago Trovati Maciel, Lise Willems, Mireille Lambert

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia.
Nicolas Chapuis, Sophie Park, Laurent Leotoing, Jerome Tamburini, Frederique Verdier, Alexa S Green

Blood· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia.
Nicolas Chapuis, Jerome Tamburini, Alexa S Green, Christine Vignon, Valerie Bardet

Clin Cancer Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Working ethics: William Beaumont, Alexis St. Martin, and medical research in antebellum America.
Alexa Green

Bull Hist Med· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia.
Sophie Park, Nicolas Chapuis, Jérôme Tamburini, Valérie Bardet, Pascale Cornillet-Lefebvre, Alexa Green

Haematologica· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody.
Nicolas Chapuis, Jérôme Tamburini, Pascale Cornillet-Lefebvre, Lucile Gillot, Valérie Bardet, Alexa S Green

Haematologica· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting translation in acute myeloid leukemia: a new paradigm for therapy?
Jerome Tamburini, Alexa S Green, Nicolas Chapuis, Valerie Bardet, Catherine Lacombe

Cell Cycle· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia.
Jerome Tamburini, Alexa S Green, Valerie Bardet, Nicolas Chapuis, Sophie Park

Blood· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis